HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pheromone-based fragrances

This article was originally published in The Rose Sheet

Executive Summary

Sense of Smell Institute, the research and education arm of the Fragrance Foundation, releases white paper -- "Human Pheromones: What's Purported, What's Supported" -- discounting currently marketed products containing fragrance materials for alleged pheromonal effects. Certain steroid molecules including androstadienone and estratetraenol "have been declared to be human pheromones based upon the false premise that humans have a functional vomeronasal organ, which they don't," University of Pennsylvania researchers say. "Consequently, selling and marketing of these fragrance materials as pheromonal products is not based upon valid information." In fact, "there are no published, scientifically-constructed, bioassay-guided studies that have lead investigators through the complex maze of compounds found on the human body to one or more elements that possess pheromonal activity," they add. They note, however, that human body odors do contain substances that alter mood and endocrine function; a company willing to make the investment to isolate such compounds could have the makings for a product of "tremendous potential," the authors say. Androstadienone is the central ingredient in Henkel's Dial for Men Magnetic body wash for young men seeking women and in got2b magnetik hair gel, marketed by Henkel's Schwarzkopf division (1"The Rose Sheet" July 13, 2009)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel